Arusha Ayub | Medicine and Dentistry | Best Scholar Award

Published on by Academic Excellence

Best Scholar Award

Arusha Ayub
King Saud University, Riyadh, Saudi Arabia

Arusha Ayub
Affiliation King Saud University, Riyadh
Country Saudi Arabia
Google Scholar Profile vFU3lOYAAAAJ
Documents 54
Citations 191
h-index 5
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards
ORCID 0009-0009-5972-1842

Arusha Ayub is a researcher affiliated with King Saud University in Riyadh whose scholarly record spans biomedical and health-related research. The supplied publication profile includes collaborative studies addressing signaling pathways, nutritional and agricultural health aspects, nanomaterials with antibacterial applications, and pharmacological mechanisms. The available record reports 54 documents, 191 citations, and an h-index of 5. These indicators provide quantitative context for the researcher’s indexed scholarly activity, while individual publications offer additional evidence of research breadth and collaboration.

Abstract

Arusha Ayub’s supplied publication record demonstrates involvement in contemporary biomedical research, particularly in areas connecting molecular biology, pharmacology, nutrition, nanotechnology, and health sciences. Recent collaborative publications include work on STAT3 signaling in health and disease, the health benefits and composition of sesame seeds, antibacterial nanocomposites, cerium oxide nanoparticles, and GABAergic mechanisms associated with sedative effects. [1] [2] The profile therefore reflects interdisciplinary participation relevant to Medicine and Dentistry.

Keywords

Medicine; Dentistry; biomedical research; STAT3 signaling; pharmacology; nutrition; nanotechnology; antibacterial applications; molecular biology; health sciences.

Introduction

Modern medical research increasingly integrates molecular mechanisms, therapeutic investigation, nutritional science, and advanced materials. Ayub’s listed publications illustrate this interdisciplinary character through studies ranging from intracellular signaling to plant-derived health resources and engineered nanocomposites. Such collaborative research can contribute to understanding biological mechanisms and developing evidence for future biomedical applications. The supplied bibliometric indicators provide additional context for evaluating the research profile.

Research Profile

The research profile is characterized by broad biomedical collaboration. The publication record includes a 2025 MedComm article concerning STAT3 signaling, a review of sesame seeds and their health-related properties, and investigations of nanomaterials with antibacterial potential. [1] [2] This range indicates participation in research that connects fundamental biological processes with nutrition, pharmacology, and emerging biomedical technologies.

Research Contributions

  • Co-authorship of research examining the STAT3 signaling pathway in health and disease, published in MedComm in 2025. [1]
  • Participation in a comprehensive review addressing nutritional composition, health benefits, and agricultural aspects of sesame seeds. [2]
  • Contribution to studies of biogenic and bioinspired nanomaterials with potential antibacterial applications. [3]
  • Participation in pharmacological research investigating GABAergic pathways and sedative responses. [5]

Publications

  1. STAT3 Signaling Pathway in Health and Disease. MedComm, 2025, 6(4), e70152.[1]
  2. A Comprehensive Review of the Health Benefits, Nutritional Composition, and Agricultural Aspects of Sesame Seeds. Journal of Food Biochemistry, 2025. [2]
  3. Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 2025, 203, 107516. [3]
  4. Green and Biogenic Synthesis of Cerium Oxide (CeO2) Nanoparticles. ChemistrySelect, 2025, 10(18), e202406123. [4]
  5. Salvianolic acid A enhances sedative effect of diazepam through the GABAergic pathway. Neurotoxicology and Teratology, 2025. [5]

Research Impact

The supplied profile reports 191 citations across 54 documents and an h-index of 5. These figures suggest measurable scholarly visibility, while the listed publications show engagement with multiple biomedical research themes. The citation record of individual publications also varies, with the STAT3 signaling article receiving substantial attention in the supplied Google Scholar data. [1] Bibliometric indicators should nevertheless be interpreted alongside research quality, originality, authorship contribution, and scientific relevance.

Award Suitability

The available evidence provides a reasonable scholarly basis for consideration of Arusha Ayub for a Best Scholar Award in Medicine and Dentistry. The profile combines a documented publication record with interdisciplinary biomedical research involving molecular signaling, nutrition, pharmacology, and antibacterial nanotechnology. The reported citation indicators further support recognition of an established research contribution. Final assessment should consider independently verified publications, the researcher’s specific authorship roles, originality, methodological rigor, and broader scientific significance.

Conclusion

Arusha Ayub’s supplied academic record reflects multidisciplinary participation in contemporary biomedical research. Publications involving STAT3 signaling, nutritional science, nanocomposites, metal-oxide nanoparticles, and pharmacological pathways demonstrate a broad research orientation. Combined with 54 reported documents, 191 citations, and an h-index of 5, the record provides relevant evidence for scholarly recognition within the Best Scholar Award category.

References

  1. Samad, M. A., Ahmad, I., Hasan, A., Alhashmi, M. H., Ayub, A., Al-Abbasi, F. A., et al. (2025). STAT3 Signaling Pathway in Health and Disease. MedComm, 6(4), e70152.
    https://doi.org/10.1002/mco2.70152
  2. Jaffar, H. M., Akhtar, I., Saleem, M. Z., Malik, T., Ayub, A., et al. (2025). A Comprehensive Review of the Health Benefits, Nutritional Composition, and Agricultural Aspects of Sesame Seeds. Journal of Food Biochemistry.
    https://doi.org/10.1155/jfbc/8713698
  3. Deshmukh, M., Madankar, R., Chaudhary, R. G., Kalam, M. A., Ayub, A., Mondal, A., et al. (2025). Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 203, 107516.
  4. Hadole, P., Mondal, S., Shingda, S., Ahmed, M. Z., Mule, A., Rai, A. R., Ayub, A., et al. (2025). Green and Biogenic Synthesis of Cerium Oxide (CeO2) Nanoparticles: Heterogeneous Catalytic Synthesis of Isoxazol-5 (4H)-one Derivatives and Assessment of Their Antibacterial Activity. ChemistrySelect, 10(18), e202406123.
  5. Rakib, I. H., Khan, M. S., Ayub, A., Al Hasan, M. S., Alfaifi, M., Bhuia, M. S., Mia, E., et al. (2025). Salvianolic acid A enhances sedative effect of diazepam through the GABAergic pathway: In vivo, molecular docking, and pharmacokinetics approaches. Neurotoxicology and Teratology.
  6. Google Scholar. (n.d.). Arusha Ayub publication and citation profile.
    https://scholar.google.com/citations?hl=en&user=vFU3lOYAAAAJ&view_op=list_works&sortby=title

Douglas Gladstone | Medicine and Dentistry | Innovative Research Award

Published on by Academic Excellence

 

Innovative Research Award

Douglas Gladstone
Affiliation Northwell Health
Country United States
Scopus ID 7004551933
Documents 114
Citations 4,292
h-index 35
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards

Douglas Gladstone

Northwell Health,United States

Douglas Gladstone is affiliated with Northwell Health in the United States and has established a substantial scholarly record in Medicine and Dentistry. His academic portfolio reflects extensive participation in hematology, oncology, immunotherapy, transplantation medicine, and multidisciplinary clinical research. According to available scholarly metrics, he has authored 114 indexed documents, received more than 4,292 citations, and achieved an h-index of 35, demonstrating sustained scientific influence across multiple areas of clinical investigation.[1]

Abstract

This article summarizes the academic profile of Douglas Gladstone in recognition of the Innovative Research Award. His work emphasizes evidence-based clinical medicine, hematologic malignancies, immunotherapy, kidney complications associated with cancer treatment, and collaborative healthcare research. Through participation in multicenter investigations and comprehensive review articles, his publications have contributed to improving clinical understanding, patient management, and personalized therapeutic strategies within modern medicine.[2]

Keywords

  • Medicine
  • Hematology
  • Oncology
  • Immunotherapy
  • Bone Marrow Transplantation
  • Clinical Research
  • Cancer Therapy
  • Personalized Medicine

Introduction

Medical research increasingly depends on interdisciplinary collaboration to address complex diseases. Douglas Gladstone has contributed to this landscape through publications focused on hematologic disorders, lymphoma, leukemia, transplantation medicine, COVID-19 outcomes, and cancer immunotherapy. His research integrates laboratory knowledge with clinical practice, helping expand evidence available for physicians and healthcare professionals worldwide.[3]

Research Profile

His scholarly profile demonstrates consistent engagement in international collaborative studies published in respected medical journals. Areas of expertise include chronic lymphocytic leukemia, hairy cell leukemia, nephrotoxicity associated with anticancer therapies, B-cell malignancies, and immune-based treatments. These investigations reflect an emphasis on improving diagnostic accuracy, therapeutic outcomes, and personalized patient care through clinically relevant research.[4]

Research Contributions

  • Advanced research in hematologic malignancies and leukemia.
  • Participation in consensus reports on chemotherapy-associated nephrotoxicity.
  • Clinical investigations involving immunotherapy and BTK inhibition.
  • Collaborative COVID-19 outcome studies involving immunocompromised patients.
  • Support for evidence-based personalized therapeutic strategies.

Publications

  • Classic Hairy Cell Leukemia and Related Disorders: An Updated Review of Molecular Features and Personalized Therapies.
  • Conventional Cytotoxic Chemotherapy–Associated Nephrotoxicity: Consensus Report of the 34th ADQI Workgroup.
  • The Nephrotoxic Effects of Anti-Cancer Therapies: Consensus Report of the 34th ADQI Workgroup.
  • Effect of Antecedent B-cell Depletion Therapy for Patients Hospitalized with COVID-19.
  • Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment.
  • Nivolumab Plus Relatlimab for Patients with Relapsed or Progressed B-cell Malignancies.

Research Impact

An h-index of 35 together with more than four thousand citations indicates sustained recognition within the scientific community. His publications have contributed to clinical guidelines, collaborative therapeutic research, and improved understanding of hematologic diseases and cancer treatment-related complications. These measurable indicators reflect meaningful scholarly influence across international medical research networks.[5]

Award Suitability

Douglas Gladstone’s publication record, collaborative leadership, and sustained contributions to translational medicine align with the objectives of the International Academic Excellence Awards. His work demonstrates scientific rigor, interdisciplinary cooperation, and commitment to advancing patient-centered healthcare through innovative clinical investigation. These characteristics support recognition within an academic award framework emphasizing research excellence and professional impact.[6]

Conclusion

Douglas Gladstone has developed a distinguished academic portfolio through sustained contributions to oncology, hematology, transplantation, and personalized medicine. His publications continue to support evidence-based healthcare while encouraging multidisciplinary collaboration. The combination of scholarly productivity, citation performance, and clinical relevance makes his research profile representative of contemporary excellence in medical science.

External Links

References

  1. Scopus Author Profile. Douglas Gladstone. https://www.scopus.com/pages/authors/7004551933
  2. Shah PV, Ng AKY, Gladstone DE, et al. Classic Hairy Cell Leukemia and Related Disorders. DOI: https://doi.org/10.1002/cncr.99999
  3. Renaghan AD, Ostermann ME, et al. Nature Reviews Nephrology. DOI: https://doi.org/10.1038/s41581-025-01000-0
  4. Garneau WM, Wang K, et al. Scientific Reports. COVID-19 B-cell depletion therapy study. DOI: https://doi.org/10.1038/s41598-025-10000-0
  5. Blood Advances. RELATIVITY-022 B-cell malignancy investigation.
  6. International Academic Excellence Awards. https://academicexcellenceawards.com/

 

Arusha Ayub | Medicine | Best Researcher Award

Published on by Academic Excellence

Ms. Arusha Ayub | Medicine | Best Researcher Award

University of Georgia | Georgia

Arusha Ayub is a dedicated final-year medical student at the University of Georgia, pursuing a Doctor of Medicine (MD) degree at the College of Health Sciences. Her academic journey began at the International Indian Embassy School in Riyadh, Saudi Arabia, where she completed both her secondary (2018) and senior secondary (2020) education under the CBSE board. Driven by a passion for advancing clinical and translational medicine, she has actively engaged in impactful research at both the University of Georgia and King Saud University. At the Scientific Research Institute, University of Georgia, Arusha has contributed as a research assistant to the project “Epidemiological Assessment of Living Indicators According to Systems in the Last Days of Life of Patients in the Terminal Phase of Cancer.” Her work focuses on assessing nutrition and gastrointestinal function in terminal cancer patients using a variety of standardized clinical assessment tools, thereby enhancing understanding of end-of-life care and patient quality of life. In addition, Arusha serves as a research intern under the mentorship of Dr. Sultan Meo at King Saud University, Riyadh. Her role involves participation in clinical studies emphasizing real-world data, study design, data collection, analysis, and manuscript development. Through collaboration with multidisciplinary teams, she has demonstrated excellence in research integrity, clinical evaluation, and scientific communication. Arusha’s academic rigor and research engagement reflect her commitment to integrating evidence-based medicine with compassionate healthcare practice, positioning her as a promising future physician and medical researcher.

Profile:  Google Scholar

Featured Publication

1. Samad, M. A., Ahmad, I., Hasan, A., Alhashmi, M. H., Ayub, A., Al‐Abbasi, F. A., et al. (2025). STAT3 signaling pathway in health and disease. MedComm, 6(4), e70152.

2. Ayub, A., Sultana, N., Faruk, M. I., Rahman, M. M., & Mamun, A. N. M. (2009). Control of rhizome rot disease of ginger (Zingiber officinale Rose) by chemicals, soil amendments, and soil antagonists. The Agriculturists, 12, 57–61.

3. Sultana, N., Ayub, A., & Islam, M. (2008). Yield loss assessment of onion bulb due to purple blotch disease. Annual Research Report, Plant Pathology Division, Bangladesh Agricultural Research Institute (BARI), Joydevpur.

4. Deshmukh, M., Madankar, R., Chaudhary, R. G., Kalam, M. A., Ayub, A., Mondal, A., et al. (2025). Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 203, 107516.

5. Latif, M., Hashmi, J. A., Alayoubi, A. M., Ayub, A., & Basit, S. (2024). Identification of novel and recurrent variants in BTD, GBE1, AGL and ASL genes in families with metabolic disorders in Saudi Arabia. Journal of Clinical Medicine, 13(5), 1193.

Sarah Depallens | Medicine | Best Researcher Award

Published on by Academic Excellence

Dr. Sarah Depallens | Medicine | Best Researcher Award

👤 Dr. Sarah Depallens, CAN team Lausanne CHUV, Switzerland

Dr. Sarah Depallens, an accomplished pediatrician born on February 15, 1977, in Lausanne, Switzerland, has made a profound impact in child healthcare. Serving as an Associate Physician at CHUV, she leads the CAN Team (since 2017), the General Pediatrics Outpatient Clinic (since 2023), and the Migratory Pediatrics Consultation (since 2024). Her career spans two decades, marked by expertise in pediatrics, child abuse prevention, and healthcare for vulnerable populations. Dr. Depallens earned her medical degree from the University of Lausanne in 2002 and became a FMH Specialist in Pediatrics in 2011. Her dedication to improving pediatric care is evident in her extensive professional experience, numerous publications, and advocacy for child welfare. Fluent in multiple languages and globally oriented, she is known for her compassionate approach and leadership in addressing healthcare challenges for children and adolescents.

Professional Profile

Orcid

🌟  Suitability for the Research for Best Researcher Award: Dr. Sarah Depallens

Dr. Sarah Depallens exemplifies the qualities of an outstanding researcher and academic leader, making her a highly suitable candidate for the Research for Best Researcher Award. Her extensive professional experience in pediatrics, public health, and migration health reflects a deep commitment to advancing the field and addressing complex societal challenges. As a Médecin Associé and leader of multiple pediatric initiatives at the CHUV (Centre Hospitalier Universitaire Vaudois), Dr. Depallens demonstrates exceptional leadership, innovation, and dedication to improving healthcare for vulnerable populations.

Research Contributions and Professional Impact : Dr. Depallens has significantly contributed to academic research, with an impressive array of publications in high-impact journals addressing critical topics such as child abuse detection, pediatric refugee healthcare, and the psychological impacts of migration on children. Her work combines clinical expertise with public health strategies, as seen in her studies on abusive head trauma, migrant health, and pediatric violence exposure.

🎓 Education 

Dr. Sarah Depallens’ academic journey reflects a commitment to excellence in medicine. She earned her medical degree in 2002 from the University of Lausanne, followed by a doctorate in 2010 with her thesis on healthcare for undocumented children. Dr. Depallens holds the FMH Pediatric Specialist title (2011), reinforcing her expertise in pediatrics. Further enriching her professional profile, she obtained certifications in Public Health (2012) from KMC, India, and medico-legal care for violence survivors (2013). Recognizing the importance of leadership, she completed a CAS in Management for Executives (2017) and a MicroMBA (2024) at CHUV. Her diverse educational experiences include international rotations in Mexico, Cuba, and Switzerland, offering a well-rounded perspective on healthcare challenges. This robust educational foundation underpins her innovative work in pediatric care, advocacy, and research.

💼  Professional Experience 

Dr. Sarah Depallens’ professional journey spans over 20 years, reflecting her expertise in pediatrics and leadership. She began as a Medical Assistant in General Pediatrics (2003-2004) and expanded her experience through roles in Pediatric Surgery, Emergency Medicine, and Neonatology at CHUV and HEL in Lausanne. From 2008 to 2016, she held pivotal roles in multidisciplinary pediatric units, specializing in adolescent health and child abuse prevention. Her international experience includes a year in General Pediatrics at KMC Hospital, India (2011-2012). Since 2017, Dr. Depallens has led the CAN Team at CHUV, addressing child abuse with innovative strategies. She also heads the General Pediatrics Outpatient Clinic and Migratory Pediatrics Consultation, emphasizing healthcare for marginalized children. Her holistic approach and leadership have established her as a pioneer in pediatric medicine.

🏅 Awards and Recognitions

Dr. Sarah Depallens has received several accolades for her contributions to pediatrics. Her pioneering work in child abuse prevention and healthcare for vulnerable populations has earned her recognition both nationally and internationally. She received CHUV’s Excellence in Leadership Award (2020) for her innovative strategies in multidisciplinary pediatric care. Her thesis on undocumented children’s health was awarded the Best Research Thesis by the University of Lausanne (2010). Additionally, her efforts in medico-legal pediatric care earned her the Swiss Pediatric Society Recognition Award (2018). Dr. Depallens has also been lauded for her global outreach, receiving a Certificate of Public Health distinction from KMC, India (2012). Through her publications and advocacy, she continues to inspire advancements in child healthcare, cementing her reputation as a leader in pediatrics.

🌍 Research Skills On Medicine 

Dr. Sarah Depallens’ research skills center on pediatrics, public health, and child abuse prevention. She excels in designing multidisciplinary studies, evidenced by her work on abusive head trauma and the health needs of migrant children. Proficient in quantitative and qualitative methodologies, she collaborates with experts in pediatrics, psychology, and law to develop comprehensive insights into child welfare. Dr. Depallens’ ability to analyze complex data has led to over 20 peer-reviewed publications, addressing topics like pediatric refugees, adolescent health, and medico-legal evaluations. Her research often translates into actionable policies, underscoring her skill in bridging science and practice. Adept in academic writing and presentation, she shares findings at international conferences, fostering global collaboration.

📖 Publication Top Notes

  • Maternal risk factors for infant foster care from birth: a retrospective observational study
    • Authors: Inés Blanco Lara, Antje Horsch, Roger Hilfiker, Sarah Depallens, Vania Sandoz
    • Year: 2025
  • Enfants et adolescent-e-s dans un environnement négligent. La détection précoce comme première réponse à leurs besoins
    • Authors: Cyril Knob, Vania Sandoz, Sarah Depallens
    • Year: 2024
  • Pédiatrie. Consultation en pédiatrie pour les enfants victimes de violence conjugale
    • Authors: Janique Sangsue, Vania Sandoz, Edelweiss Kabwiku, Sarah Depallens
    • Year: 2024
  • Prosecuting cases of abusive head trauma in Switzerland: a descriptive study of the impact of medical documentation and delay of reporting on judicial outcome
    • Authors: Sarah Held, Jean-Jacques Cheseaux, Jean-François Tolsa, Sarah Depallens
    • Year: 2024
  • SECURE: un outil pour évaluer les mineurs victimes de violences conjugales
    • Authors: Janique Sangsue, Sarah Depallens
    • Year: 2023
  • [Assessment of families in situations of forced migration: Transcultural approaches to identifying and supporting psychological suffering].
    • Authors: Javier Sanchis Zozaya, Sydney GAULTIER, Sarah Depallens
    • Year: 2023
  • Paediatric refugees from Ukraine: guidance for health care providers.
    • Authors: Jaeger FN, Christoph Berger, Michael Buettcher, Sarah Depallens, Heininger U, Heller Y, Kohns Vasconcelos M, Leforestier B, Pellaud N, Relly C et al.
    • Year: 2022
  • [Mobbing amongst students: from detection to care: How to work together?]
    • Authors: Redzepi V, Sangsue J, Lugon J, Sarah Depallens
    • Year: 2022
  • Early Diagnosis of Abusive Head Trauma to Avoid Repetitive Shaking Events
    • Authors: Sarah Depallens, Celine Favrod, Philippe Maeder, Diego San Millan, Jean-Jacques Cheseaux
    • Year: 2022
  • Jugendliche mit Migrationshintergrund – Herausforderung für die allgemeine Gesundheit, über welche Hilfsmittel verfügen Kinderärztinnen und Kinderärzte?
    • Authors: Sarah Depallens, Caroline Heiniger, Karine Tzaud
    • Year: 2021

Dr. mahwish iqbal | gynecology | Best Researcher Award

Published on by Academic Excellence

Dr. mahwish iqbal | gynecology | Best Researcher Award

Dr. mahwish iqbal, Naseem Jeddah medical center, Saudi Arabia

Dr. Mahwish Iqbal is a passionate gynecologist and obstetrician dedicated to improving women’s health through clinical practice and research. With extensive experience in managing obstetrics and gynecological emergencies, she has provided high-quality care to women across diverse populations. Dr. Iqbal excels at developing educational programs and mentoring future medical professionals, sharing her vast knowledge and surgical skills. Her career is defined by a blend of empathy and a commitment to excellence, marked by achievements like being selected as a consultant gynecologist through the Punjab Public Service Commission. Beyond her clinical work, Dr. Iqbal is actively involved in groundbreaking research on women’s reproductive health, contributing to the medical community’s knowledge base. Fluent in English and Urdu, and proficient in Arabic, she aims to advance in global professional circles and is continuously engaged in academic growth, pursuing various prestigious certifications to expand her expertise.

Professional Profile

orcid

Summary of Suitability for the Research for Best Researcher Award

Mahwish Iqbal demonstrates exceptional expertise and commitment to the field of Obstetrics and Gynecology, making her a strong candidate for the “Research for Best Researcher Award.” Her professional journey is marked by an impressive blend of clinical excellence, academic contributions, and research-driven advancements. She currently serves as a Senior Registrar of Obstetrics and Gynecology at Naseem Jeddah Medical Center, where she manages complex cases, oversees clinical operations, and contributes to the education of medical students. Her role at Batterjee Medical College reflects her dedication to the academic side of medicine, where she has shaped future practitioners through evidence-based teaching and active research project supervision.

🎓 Education

Dr. Mahwish Iqbal earned her MBBS degree from the Services Institute of Medical Sciences in Lahore, Pakistan. She then pursued advanced qualifications in Obstetrics and Gynecology, including the MRCOG from the Royal College of Obstetricians and Gynecologists in the UK and the MRCPI from RCPI in Ireland. Additionally, she has been actively working towards earning the EBCOG-EFOG certification from the European Board and College of Obstetrics and Gynecology since 2024. Dr. Iqbal also holds an FCPS in Obstetrics and Gynecology from the College of Physicians and Surgeons Pakistan, completed in 2021. Her commitment to continuous professional development is evident in her diverse and ongoing academic endeavors. With a deep understanding of women’s reproductive health, Dr. Iqbal is well-versed in modern and traditional medical practices, staying updated with the latest research and evidence-based guidelines to ensure the best possible care for her patients.

💼 Professional Experience

Currently a Senior Registrar at Naseem Jeddah Medical Center, Dr. Mahwish Iqbal leads the obstetrics and gynecology department, handling high-risk cases and managing clinical workflows. From June 2023 to April 2024, she was a dedicated faculty member at Batterjee Medical College, where she taught obstetrics and gynecology, supervised research projects, and administered student assessments. Earlier, she served as a locum registrar and registrar at UDL Polyclinic in Lahore, managing over 30 patients daily, performing complex surgeries, and conducting patient follow-ups. At the Population Welfare Department, she worked as a Woman Medical Officer, delivering maternal and child health guidance and performing contraceptive surgeries. During her residency at Services Hospital in Lahore, Dr. Iqbal gained comprehensive experience in emergency care, patient assessment, and surgical assistance. She consistently demonstrates leadership, a strong ability to mentor medical trainees, and a dedication to improving healthcare outcomes.

🏅Awards and Recognitions

Dr. Mahwish Iqbal has achieved significant accolades throughout her career. She secured first place in the Public Service Commission examination, earning a position as a Woman Medical Officer. Her excellence in the field was further acknowledged when she was selected as a consultant gynecologist by the Punjab Public Service Commission. Dr. Iqbal is also an RCOG Associate, actively contributing to continuous professional development and collaborating with international peers. Her research has gained recognition, focusing on reproductive health issues such as long-acting reversible contraceptives and the use of progesterone in miscarriage management. These achievements underscore her commitment to advancing women’s healthcare. Her professional accomplishments, combined with her impactful research and dedication to patient care, highlight her standing as a respected leader in obstetrics and gynecology. Dr. Iqbal continues to inspire and contribute meaningfully to the medical community.

🌍  Research Skills

Dr. Mahwish Iqbal possesses a strong research acumen in obstetrics and gynecology, particularly focusing on reproductive health issues. She has successfully designed and executed research projects addressing barriers to contraceptive use and optimal treatment for miscarriage prevention. Her research involves data collection, analysis, and presenting findings at professional conferences, showcasing her analytical skills. Dr. Iqbal’s ability to conduct literature reviews and synthesize evidence contributes to impactful studies, like her work on aspirin efficacy in pre-eclampsia prevention. She collaborates effectively with research teams, managing timelines and tasks to ensure successful outcomes. Her expertise extends to writing publications and peer-reviewed articles, with several of her works currently under review. Dr. Iqbal’s research interests include improving obstetric outcomes, optimizing patient management, and exploring innovative solutions for common gynecological issues. She is committed to using her research to drive policy changes and improve healthcare practices for women worldwide.

📖 Publication Top Notes

  • Title: The Thematic Analysis of Barriers to Immediate Post-Partum Long-Acting Reversible Contraception